In this chapter, we focus on two topics: the lack of enforcement of existing U.S. Department of Defense (DOD) guidelines and procedures and the role of the program manager in the acquisition process.

Animal testing has long been a standard component of drug development, but advances in science and regulations are reshaping that paradigm. Recent milestones, including the 2022 FDA Modernization Act ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals as well as alleviating animal suffering. But ...

DONGGUAN, GUANGDONG, CHINA, August 11, 2026 /EINPresswire.com/ -- As global manufacturing continues to place greater ...

Soft biological tissues are important constituents that influence human physiology and disease since they impact cell behavior during tissue development, maintenance and repair. Most existing methods ...

In the past year, we have seen a growing interest and commitment to the environment at both the business and consumer levels. More businesses are focused on providing environmentally friendly products ...

This appendix presents a brief overview of the defense acquisition process. 1 The diagram below from the U.S. Department of Defense (2008:12 enclosure 2) depicts the development of defense systems as ...